type 2 diabetes

Lexicon Pharma's Never-Ending Diabetes Drug Partner Talks
The Street
Thu, 08/1/13 - 09:14 am
Lexicon Pharmaceuticals
LX4211
type 2 diabetes
diabetes
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Wed, 07/31/13 - 09:20 am
Biodel
BIOD-123
type 1 diabetes
type 2 diabetes
diabetes
First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for TRADJENTA® (linagliptin) Tablets in Type 2 Diabetes
Yahoo/PR Newswire
Wed, 07/31/13 - 09:11 am
Tradjenta
diabetes
type 2 diabetes
Boehringer Ingelheim
Eli Lilly
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Yahoo/Market Wired
Sun, 06/23/13 - 11:30 am
Sanofi
U300
insulin
type 2 diabetes
diabetes
Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:28 am
lixisenatide
type 2 diabetes
diabetes
Sanofi
Glaxo Diabetes Drug Shows Gastrointestinal Side Effects
Bloomberg
Sun, 06/23/13 - 11:22 am
GSK
albiglutide
diabetes
type 2 diabetes
Phase III data show significant reductions in blood glucose with investigational compound empagliflozin used as monotherapy in adults with type 2 diabetes
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:20 am
empagliflozin
type 2 diabetes
diabetes
Boehringer Ingelheim
Spinning RECORD: Battle Over Avandia Heats Up Two Weeks Before Crucial FDA Meeting
Forbes
Fri, 05/24/13 - 11:08 am
Avandia
type 2 diabetes
diabetes
GSK
FDA
Steve Nissen
Glaxo Alleges Errors In Nissen's Critique Of FDA's Handling Of Avandia Comment Now Follow Comments
Forbes
Fri, 05/24/13 - 11:09 am
Steve Nissen
GSK
Avandia
type 2 diabetes
diabetes
Strong Drug Performance Boosts Santarus Higher
Forbes
Fri, 05/24/13 - 10:48 am
Santarus
Cycloset
diabetes
type 2 diabetes
FDA reviewing heart risks of Glaxo diabetes pill
Yahoo/AP
Sat, 04/13/13 - 12:11 pm
GSK
Avandia
diabetes
type 2 diabetes
Repros Gets Additional Patents
Yahoo/Zacks
Sat, 04/13/13 - 11:25 am
type 2 diabetes
testosterone
Repros
Androxal
FDA OKs first-of-a-kind diabetes drug from J&J
Yahoo/AP
Sat, 03/30/13 - 11:01 am
JNJ
diabetes
Invokana
type 2 diabetes
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sun, 03/24/13 - 12:27 pm
JNJ
Invokana
type 2 diabetes
diabetes
pulmonary arterial hypertension
Treprostinil
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha
Sat, 03/9/13 - 12:29 pm
type 2 diabetes
JNJ
diabetes
canagliflozin
Takeda Put Actos Sales Ahead of User Safety, Witness Says
Bloomberg
Wed, 03/6/13 - 09:59 am
Takeda
Actos
diabetes
type 2 diabetes
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for Cycloset (bromocriptine mesylate) for the Management of Type 2 Diabetes
Yahoo/BusinessWire
Wed, 03/6/13 - 09:44 am
Santarus
type 2 diabetes
Cycloset
VeroScience
How Serious Is This News for Diabetes Drugmakers?
Motley Fool
Sat, 03/2/13 - 04:00 pm
pancreatitis
diabetes
type 2 diabetes
Merck
AstraZeneca
Bristol-Myers Squibb
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Sat, 02/16/13 - 12:23 pm
type 2 diabetes
Takeda
diabetes
cancer
Actos

Pages